0001437749-24-006507.txt : 20240304
0001437749-24-006507.hdr.sgml : 20240304
20240304210337
ACCESSION NUMBER: 0001437749-24-006507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts David B
CENTRAL INDEX KEY: 0001365731
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 24717947
MAIL ADDRESS:
STREET 1: 55 BRADFORD STREET
CITY: NEEDHAM
STATE: MA
ZIP: 02492
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-02-29
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365731
Roberts David B
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
President and Director
0
Common Stock
2024-02-29
4
A
0
2649
0
A
19329
D
Common Stock
2024-02-29
4
M
0
6
0
A
19335
D
Common Stock
2024-02-29
4
F
0
196
70
D
19139
D
Dividend Equivalent Rights
2024-02-29
4
M
0
6.683
0
D
Common Stock
6.683
20.0592
D
These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years.
Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
/s/ David C. Hissong
2024-03-04